Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
- 1 May 1992
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 339 (8803), 1195-1196
- https://doi.org/10.1016/0140-6736(92)91135-u
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stageBritish Journal of Haematology, 1990
- BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol- resistant epitopeBlood, 1989
- Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein fromSaponaria officinalisVirchows Archiv B Cell Pathology Including Molecular Pathology, 1987
- Ribosome‐inactivating proteins up to dateFEBS Letters, 1986
- The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsBlood, 1985